Price $86.98 |
Market Cap
130.62B
|
Sector Health Care |
Div. Growth
27.50%
|
|
P/E
39.3
|
P/B
-
|
P/S
3.95
|
Dividend %
5.40%
|
|
P/CF
49.4
|
P/FCF
19.4
|
Op. Cash Flow
13.44M
|
FCF
4.5
|
|
Op. Margin
20.00%
|
Net Margin
9.80%
|
ROE
-39.10%
|
ROI
21.80%
|
|
ROA
5.60%
|
EPS Growth
-54.90%
|
Current Ratio
1.0
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Encision Inc (ECIA) | $0.48 | - | - | 5.6M | Strong Buy |
| NantHealth Inc (NH) | $1.10 | - | - | 120.6M | Strong Buy |
| Natus Medical Inc (NTUS) | $31.55 | - | - | 1.11B | Strong Buy |
| Novelion Therapeutics Inc (USA (NVLNF) | $0.74 | - | - | 13.3M | Strong Buy |
| Ocugen Inc (OCGN) | $0.41 | - | - | 5.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
